婴幼儿乙肝疫苗两剂与三剂方案免疫原性随机对照试验
该随机临床试验在2-18月龄儿童中比较两剂与三剂乙肝疫苗方案的免疫原性。基础免疫后1个月,三组抗-HBs≥10 mIU/mL血清保护率相近,两剂组几何平均滴度较低;3年后加强剂量后三组回忆应答相似,异源两剂组几何平均滴度数值上高于三剂组。异源两剂方案比同源两剂方案免疫原性更强且局部反应更少。
要点
- 两剂与三剂乙肝疫苗基础免疫后血清保护率均高且相近。
- 3年后加强剂量后三组回忆应答相似,异源两剂组几何平均滴度数值上最高。
- 异源两剂方案局部反应显著少于同源两剂方案。
核心结论
- 2月龄和12月龄两剂及2、4、18月龄三剂乙肝疫苗方案在3年后加强剂量后回忆应答相似。
- 异源两剂方案比同源两剂方案免疫原性更强且反应原性更低。
研究设计与样本
- 随机临床试验,实验组2月龄入组随机接受同源或异源两剂方案,对照组18月龄入组已接受同源三剂方案。
- 所有组在3年后接受加强剂量Twinrix。
主要发现
- 基础免疫后1个月,抗-HBs≥10 mIU/mL血清保护率:异源两剂91.7%、同源两剂90.9%、三剂94.2%。
- 基础免疫后两剂组几何平均滴度低于三剂组。
- 加强剂量后回忆应答率:异源两剂97.2%、同源两剂95.5%、三剂92.7%。
- 加强剂量后几何平均滴度异源两剂组9380.5 mIU/mL,三剂组6900.6 mIU/mL(P = .4)。
临床怎么用
- 婴儿乙肝疫苗接种可考虑两剂方案,异源两剂方案免疫原性更强且局部反应更少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A 2-dose hepatitis B vaccination schedule is highly immunogenic in children aged ≥1 year, but data for infants are scarce. Our goal was to compare the immunogenicity of 2- and 3-dose hepatitis B vaccination schedules in this population. METHODS: Children in the experimental group were recruited at 2 months of age and randomized to receive a homologous (Infanrix-hexa/Infanrix-hexa) or heterologous (Infanrix-hexa/Twinrix) 2-dose schedule at 2 and 12 months. Children in the control group were recruited at 18 months and had received a homologous 3-dose schedule (Infanrix-hexa/Infanrix-hexa/Infanrix-hexa) at 2, 4, and 18 months. All groups received a challenge dose (Twinrix) 3 years later. RESULTS: One month after the primary series, seroprotection rates (anti-HBs ≥10 mIU/mL) were high and similar among the 3 groups (heterologous 2-dose, 91.7%; homologous 2-dose, 90.9%; 3-dose, 94.2%). Geometric mean titers (GMTs) were lower in the 2-dose groups than in the 3-dose group. Post-challenge dose, the majority exhibited an anamnestic response, similar across all 3 groups (heterologous 2-dose, 97.2%; homologous 2-dose, 95.5%; 3-dose, 92.7%). GMTs were numerically higher in the heterologous 2-dose group (9380.5 mIU/mL) than in the 3-dose group (6900.6 mIU/mL) (P = .4). The proportion exhibiting local reactions was significantly lower after the heterologous 2-dose schedule than after the homologous 2-dose schedule. CONCLUSIONS: The anamnestic response 3 years after 2-dose (2 and 12 months) and 3-dose (2, 4, and 18 months) hepatitis B vaccination schedules was similar. The heterologous 2-dose schedule was more immunogenic and less reactogenic than the homologous 2-dose schedule.
引用
- Kegbevi KB, Febriani Y, Sauvageau C, et al. Immunogenicity of Two Versus Three Doses of Hepatitis B Vaccine When Administered to Children Aged 2-18 Months: A Randomized Clinical Trial. J Infect Dis. 2026. PMID: 41739814. doi:10.1093/infdis/jiag122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。